Pulmonary granulomatous inflammation: From sarcoidosis to tuberculosis

Seminars in Respiratory Infections

Volumn 18, Issue 1, 2003, Pages 23-32

  Perez, Rafael L ^b   Rivera Marrero, Carlos A ^b   Roman, Jesse ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

DISEASE COURSE; GRANULOMATOUS INFLAMMATION; HUMAN; IMMUNE SYSTEM; LUNG DISEASE; LUNG FIBROSIS; LUNG GRANULOMA; LUNG INFECTION; LUNG SARCOIDOSIS; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SARCOIDOSIS; TUBERCULOSIS;

GRANULOMA, RESPIRATORY TRACT; HUMANS; PNEUMONIA; SARCOIDOSIS, PULMONARY; TUBERCULOSIS, PULMONARY;

EID: 0345505729     PISSN: 08820546     EISSN: None     Source Type: Journal    
DOI: 10.1053/srin.2003.50005     Document Type: Review

References (50)

1. Williams GT, Williams WJ: Granulomatous inflammation-a review. J Clin Pathol 36:723-733, 1983
2. Kunkel SL, Chensue SW, Strieter RM, et al: Cellular and molecular aspects of granulomatous inflammation. Am J Respir Cell Mol Biol 1:439-447, 1989
3. Roman J, Jeon Y-J, Gal A, et al: Distribution of extracellular matrices, matrix receptors, and transforming growth factor β-1 in human and experimental lung granulomatous inflammation. Am J Med Sci 309:124-133, 1995
4. Newman LS, Rose CS, Maier L: Sarcoidosis. N Engl J Med 336:1224-1234, 1997
5. Moller DR: Cells and cytokines involved in the pathogenesis of sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 16:24-31, 1999
6. Statement on sarcoidosis. Am J Respir Crit Care Med 160:736-755, 1999
7. Modlin RL, Hofman FM, Meyer PR, et al: In situ demonstration of T lymphocyte subsets in granulomatous inflammation: Leprosy, rhinoscleroma and sarcoidosis. Clin Exp Immunol 51:430-438, 1983
8. Yeager H Jr, Azumi N, Underhill CB: Fibrosis: The formation of the granuloma matrix, in Rom WN, Garay SM (eds): Tuberculosis. New York, Little, Brown & Co., 1996, pp 363-370
9. Agostini C, Adami F, Semenzato G: New pathogenetic insights into the sarcoid granuloma. Curr Opin Rheumatol 12: 71-76, 2000
10. Moller DR, Forman JD, Liu MC, et al: Enhanced expression of IL-12 associated with Th1 cytokine profiles in active pulmonary sarcoidosis. J Immunol 156:4952-4960, 1996
11. Butcher EC: Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 67:1033-1036, 1991
12. Gudmundsson G, Hunninghake GW: Interferon-γ is necessary for the expression of hypersensitivity pneumonitis. J Clin Invest 99:2386-2390, 1997
13. Wang J, Wakeham J, Harkness R, et al: Macrophages are a significant source of type 1 cytokines during mycobacterial infection. J Clin Invest 103:1023-1029, 1999
14. Moore KW, Malefyt RDW, Coffman RL, et al: Interleukin-10 and the interleukin-10 receptor. Ann Rev Immunol 19: 683-765, 2001
15. Shanley TP, Vasi N, Denenberg A: Regulation of chemokine expression by IL-10 in lung inflammation. Cytokine 12:1054-1064, 2000
16. Kulkarni AB, Karlsson S: Transforming growth factor-β1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease. Am J Pathol 143:3-9, 1993
17. Border WA, Ruoslahti E: Transforming growth factor-β in disease: The dark side of tissue repair. J Clin Invest 90:1-7, 1992
18. Rolfe MW, Stadiford TJ, Kunkel SL, et al: Interleukin-1 receptor antagonist expression in sarcoidosis. Am Rev Respir Dis 148:1378-1384, 1993
19. Nagai S, Aung H, Takeuchi M, et al: IL-1 and IL-1 inhibitory activity in the culture supernatants of alveolar macrophages from patients with interstitial lung diseases. Chest 99:674-680, 1991
20. Kunkel SL, Lukacs NW, Strieter RM, et al: Th1 and Th2 responses regulate experimental lung granuloma development. Sarcoidosis Vasc Diffuse Lung Dis 13:120-128, 1996
21. Roman J: Extracellular matrices in the pathogenesis of injury and repair, in Schwarz M, King T (eds): Interstitial Lung Disease. London, BC Decker, Inc., 1998, pp 207-227
22. Eklund AG, Sigurdardottir O, Ohrn M: Vitronectin and its relationship to other extracellular matrix components in bronchoalveolar lavage fluid in sarcoidosis. Am Rev Respir Dis 145:646-650, 1992
23. Bacchella L, Tinelli C, Gile LS, et al: Serum type I and type III procollagen peptide levels in sarcoidosis. Eur Respir J 9:1648-1651, 1996
24. Limper AH, Colby TV, Sanders MS, et al: Immunohistochemical localization of transforming growth factor-β1 in the nonnecrotizing granulomas of pulmonary sarcoidosis. Am J Respir Crit Care Med 149:197-204, 1994
25. Roman J: Extracellular matrices and lung inflammation. Immunol Res 15:163-178, 1996
26. Roman J, Ritzenthaler JD, Perez RL, et al: Differential modes of regulation of interleukin-1β expression by extracellular matrices. Immunol 98:228-237, 1999
27. Roman J, Ritzenthaler JD, Fenton MW, et al: Transcriptional regulation of the human interleukin 1 gene by fibronectin: Role of protein kinase C and activator protein-1 (AP-1). Cytokine 12:1581-1596, 2000
28. Perez RL, Roman J: Fibrin enhances the expression of interleukin-1β by human peripheral blood mononuclear cells. Implications in pulmonary inflammation. J Immunol 154:1879-1887, 1995
29. Perez RL, Staton GW Jr, Roman J, et al: Extravascular coagulation and fibrinolysis in murine lung inflammation induced by mycobacterial cord factor trehalose-6,6′-dimycolate. Am J Respir Crit Care Med 149:510-518, 1994
30. Garay SM: Pulmonary tuberculosis, in Rom WM, Garay S (eds): Tuberculosis. New York, Little, Brown & Company, 1996, pp 373-412
31. Barnes PF, Rom WN: Cytokine production in tuberculosis, in Rom WN, Garay S (eds): Tuberculosis. New York, Little, Brown and Company, 1996, pp 291-303
32. Barnes PF, Modlin RL: Human cellular immune responses to Mycobacterium, in Shinnick TM (ed): Tuberculosis: Current Topics in Microbiology and Immunology. Berlin, Springer-Verlag, 1996, pp 197-219
33. Yamada H, Mizumo S, Horai R, et al: Protective role of interleukin-1 in mycobacterial infection in IL-1 α/β double-knockout mice. Lab Invest 80:759-767, 2000
34. Flynn JL, Goldstein MM, Chan J, et al: Tumor necrosis factor-α is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:562-572, 1995
35. Ehlers S, Kutsch S, Ehlers EM, et al: Lethal granuloma disintegration in mycobacteria-infected TNFRp55-/-mice is dependent on T cells and IL-12. J Immunol 165:483-492, 2000
36. Altare F, Durandy A, Lamas D, et al: Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280:1432-1434, 1998
37. Cooper AM, Magram J, Ferrante J: Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 186:39-45, 1997
38. Sugawara I, Yamada H, Mizuno S: IL-4 is required for defense against mycobacterial infection. Microbiol Immunol 144:971-979, 2000
39. Saunders BM, Frank AA, Orme IM, et al: Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection. Infect Immun 68:3322-3326, 2000
40. Roach DR, Martin E, Bean AG: Endogenous inhibition of antimycobacterial immunity by IL-10 varies between mycobacterial species. Scand J Immunol 54:163-170, 2001
41. Murray PJ, Young RA: Increased antimycobacterial immunity in interleukin-10-deficient mice. Infect Immun 67:3087-3095, 1999
42. Jacobs M, Brown N, Allie N, et al: Increased resistance to mycobacterial infection in the absence of interleukin-10. Immunol 100:494-501, 2000
43. Toossi Z, Gaogate P, Shiratsuchi H, et al: Enhanced production of TGF-β by blood monocytes from patients with active tuberculosis and presence of TGF-β in tuberculous granulomatous lesions. J Immunol 154:465-473, 1995
44. Tsuda T, Dannenberg AM, Ando M, et al: Enzymes in tuberculous lesions hydrolyzing protein, hyaluronic acid and chondroitin sulfate. A study of isolated macrophages and developing and healing rabbit BCG lesions with substrate film techniques: The shift of enzyme pH optima towards neutrality in "intact" cells and tissues. J Reticuloendothel Soc 16:220-231, 1974
45. Dannenberg AM: Chemical and enzymatic host factors in resistance to tuberculosis, in Kubica GP, Wayne LG (eds): The Mycobacteria. New York, Marcel Dekker, Inc., 1984, pp 721-760
46. Munger JS, Chapman HA: Tissue destruction by proteases, in Rom WM, Garay S (eds): Tuberculosis. New York, Little, Brown & Company, 1996, pp 353-361
47. Rivera-Marrero CA, Schuyler W, Roser S, et al: Induction of MMP-9 mediated gelatinolytic activity in human monocytic cells by cell wall components of Mycobacterium tuberculosis. Microbiol Pathol 29:231-244, 2000
48. Rivera-Marrero CA, Roman J: M. tuberculosis induction of matrix metalloproteinase-9: The role of mannose and receptor-mediated mechanisms. Am J Physiol 282:L546-L555, 2002
49. Nau GL, Liaw L, Chupp GL, et al: Attenuated host resistance against Myobacterium bovis BCG infection in mice lacking osteopontin. Infect Immun 67:4223-4230, 1999
50. Dannenberg AM, Collins FM: Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products. Tuberculosis 81:229-242, 2001